COVID-19 Saliva Screening Test Potential Market Size, Share, Trends, Key Drivers, Demand and Opportu

Author : neha hande | Published On : 14 Apr 2026

"Executive Summary COVID-19 Saliva Screening Test Potential Market Size and Share Forecast

The global COVID-19 saliva screening test potential market size was valued at USD 3.13 billion in 2024 and is projected to reach USD 5.47 billion by 2032, with a CAGR of 7.23% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

COVID-19 Saliva Screening Test Potential Market research report brings into focus the key market dynamics of the sector. The COVID-19 Saliva Screening Test Potential Market study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities, challenges, risks, entry barriers, sales channels, distributors, and Porter's Five Forces Analysis. The COVID-19 Saliva Screening Test Potential report makes available fluctuations in CAGR values during the forecast period for the market. This transformation in the market landscape is mainly observed due to the moves of key players or brands, which include developments, product launches, joint ventures, mergers, and acquisitions that in turn change the view of the global face of the industry.

Market definition, market segmentation, key developments in the market, competitive analysis, and research methodology are the major topics in which this COVID-19 Saliva Screening Test Potential report is divided. This market report covers an array of factors that have an influence on the market and the keyword market industry, which includes industry insight and critical success factors (CSFs), market segmentation and value chain analysis, industry dynamics, drivers, restraints, key opportunities, technology and application outlook, country-level and regional analysis, competitive landscape, company market share analysis, and key company profiles. For sound decision-making and superior management of goods and services, these days businesses are adopting a market research report solution.

Gain clarity on industry shifts, growth areas, and forecasts in our COVID-19 Saliva Screening Test Potential Market report. Get your copy:
https://www.databridgemarketresearch.com/reports/global-covid-19-saliva-screening-test-potential-market

COVID-19 Saliva Screening Test Potential Market Review

Segments

- By Test Type
- Molecular Tests
- Antigen Tests
- Antibody Tests
- By End User
- Hospitals
- Diagnostic Laboratories
- Home Care Settings
- Others

Saliva testing for COVID-19 has emerged as a convenient and non-invasive method for screening individuals. The global market for COVID-19 saliva screening tests is expected to witness significant growth due to the ease of sample collection, reduced discomfort for patients, and potential for mass testing. The market can be segmented based on test type, including molecular tests, antigen tests, and antibody tests. Molecular tests are currently the most widely used for detecting the genetic material of the virus in saliva samples. Antigen tests are also gaining popularity for quick and cost-effective screening. Antibody tests help in identifying past infections and immune response. In terms of end users, the market caters to hospitals, diagnostic laboratories, home care settings, and others, providing flexibility in testing locations and accessibility.

Market Players

- Quest Diagnostics
- Roche Diagnostics
- Siemens Healthineers
- Abbott Laboratories
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Quidel Corporation
- PerkinElmer
- Hologic, Inc.
- Becton, Dickinson and Company

Several key players are actively contributing to the global COVID-19 saliva screening test market. Quest Diagnostics, Roche Diagnostics, and Siemens Healthineers are among the leading companies investing in developing and commercializing saliva-based testing solutions. Abbott Laboratories and Bio-Rad Laboratories are also prominent players with a focus on offering accurate and reliable testing platforms. Thermo Fisher Scientific and Quidel Corporation have introduced innovative technologies to enhance testing efficiency. PerkinElmer, Hologic, Inc., and Becton, Dickinson and Company are actively engaged in expanding their product portfolios to meet the growing demand for saliva screening tests. These market players are leveraging their research capabilities and distribution networks to meet the evolving needs of healthcare systems worldwide.

The global market for COVID-19 saliva screening tests has seen a surge in demand and innovation in response to the ongoing pandemic. Advancements in testing technology and the convenience of saliva-based tests have made them a preferred choice for individuals and healthcare providers alike. One key trend shaping the market is the development of rapid and accurate tests that can deliver results quickly, allowing for timely identification and containment of the virus. Market players are investing heavily in research and development to enhance the sensitivity and specificity of saliva tests, ensuring reliable results for screening and diagnostic purposes.

Furthermore, the market for COVID-19 saliva screening tests is witnessing collaborations and partnerships between key industry players and healthcare organizations to expand testing capabilities and reach a wider population. These strategic alliances aim to strengthen distribution networks, improve testing infrastructure, and enhance the availability of testing kits in various healthcare settings. Such partnerships also facilitate the sharing of knowledge and expertise, leading to the development of more effective testing solutions and protocols.

Moreover, the adoption of saliva testing for COVID-19 is not limited to traditional healthcare facilities but has also gained traction in non-clinical settings such as schools, workplaces, and community centers. The ease of sample collection and reduced need for trained healthcare professionals make saliva tests a practical and cost-effective option for mass screening and surveillance programs. This expansion of testing beyond hospitals and diagnostic laboratories underscores the growing importance of decentralized testing approaches in managing public health crises like the COVID-19 pandemic.

Additionally, regulatory bodies and government agencies play a crucial role in shaping the market landscape for COVID-19 saliva screening tests. Stringent regulations and guidelines regarding test validation, performance, and reporting standards are essential for ensuring the accuracy and reliability of test results. Market players must adhere to these regulatory requirements to gain approval for their testing products and maintain consumer trust in the effectiveness of saliva-based testing methods.

In conclusion, the global market for COVID-19 saliva screening tests is dynamic and evolving, driven by technological advancements, strategic partnerships, expanding testing locations, and regulatory oversight. The market is poised for continued growth as the demand for reliable and accessible testing solutions remains high. Market players need to focus on innovation, quality assurance, and collaboration to meet the evolving needs of healthcare systems and contribute to the global efforts in controlling the spread of COVID-19 through effective screening and testing strategies.The global market for COVID-19 saliva screening tests is experiencing a paradigm shift with the adoption of saliva-based testing methods. This shift is driven by the convenience, non-invasive nature, and potential for mass testing offered by saliva tests. Market players are focusing on developing innovative testing solutions to cater to the increasing demand for accurate and efficient COVID-19 screening. The market segmentation based on test types such as molecular tests, antigen tests, and antibody tests provides a diversified range of options for healthcare providers and individuals. Molecular tests are currently dominating the market for detecting the genetic material of the virus, while antigen tests offer quick and cost-effective screening solutions. Antibody tests play a crucial role in identifying past infections and immune responses, contributing to a comprehensive approach to COVID-19 screening.

Key industry players such as Quest Diagnostics, Roche Diagnostics, Siemens Healthineers, and Abbott Laboratories are at the forefront of driving advancements in saliva screening tests. These companies are investing in research and development to enhance the sensitivity and specificity of tests, ensuring accurate results for screening and diagnostic purposes. Collaborations and partnerships between market players and healthcare organizations are further expanding testing capabilities and reaching a wider population. These strategic alliances aim to strengthen distribution networks, improve testing infrastructure, and enhance the availability of testing kits across various healthcare settings.

Regulatory bodies and government agencies are playing a pivotal role in shaping the market landscape for COVID-19 saliva screening tests by setting stringent regulations and guidelines for test validation, performance, and reporting standards. Compliance with these regulations is crucial for gaining approval for testing products and maintaining consumer trust in the efficacy of saliva-based testing methods. The market's evolution towards decentralized testing approaches in non-clinical settings like schools, workplaces, and community centers underscores the importance of accessibility and affordability in scaling up COVID-19 screening efforts.

As the demand for reliable and accessible COVID-19 testing solutions continues to rise, market players must prioritize innovation, quality assurance, and collaboration to meet the evolving needs of healthcare systems. The market's trajectory is poised for sustained growth as technological advancements, strategic partnerships, and regulatory oversight shape the future of COVID-19 saliva screening tests. By staying abreast of market trends and investing in research and development, market players can contribute significantly to global efforts in controlling the spread of the virus through effective screening and testing strategies.

Uncover the company’s portion of market ownership
https://www.databridgemarketresearch.com/reports/global-covid-19-saliva-screening-test-potential-market/companies

Structured Market Research Questions for COVID-19 Saliva Screening Test Potential Market

• What is the present size of the global COVID-19 Saliva Screening Test Potential industry?


• What annual growth rate is projected for the COVID-19 Saliva Screening Test Potential sector?


• What are the main segment divisions in the COVID-19 Saliva Screening Test Potential Market report?


• Who are the established players in the global COVID-19 Saliva Screening Test Potential Market?


• What geographic areas are explored in the COVID-19 Saliva Screening Test Potential Market report?


• Who are the leading manufacturers and service providers for COVID-19 Saliva Screening Test Potential Market?


 

Browse More Reports:

 Global Portable Ultrasound System Market
 Global Post-consumer Recycled Plastics In Automotive Market
 Global Potassium Metabisulfite Market
 Global Pour Point Depressant Market
 Global Power Rental Market
 Global Preclinical Imaging Market
 Global Product Analytics Market
 Global Programmable Electronic Commercial Beverage Blender Market
 Global Proprietary HMI (Human Machine Interface) Software Market
 Global Pulmonary Drug Delivery Market
 Global Pyrometer Market
 Global Radial Farm Tire Market
 Global Railcar Unloader Market
 Global Rapid Immunoassay Test Strips/Cassettes Market
 Global Reactive Diluents Market


About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email:- corporatesales@databridgemarketresearch.com

 ""Executive Summary COVID-19 Saliva Screening Test Potential Market Size and Share Forecast

The global COVID-19 saliva screening test potential market size was valued at USD 3.13 billion in 2024 and is projected to reach USD 5.47 billion by 2032, with a CAGR of 7.23% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

COVID-19 Saliva Screening Test Potential Market research report brings into focus the key market dynamics of the sector. The COVID-19 Saliva Screening Test Potential Market study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities, challenges, risks, entry barriers, sales channels, distributors, and Porter's Five Forces Analysis. The COVID-19 Saliva Screening Test Potential report makes available fluctuations in CAGR values during the forecast period for the market. This transformation in the market landscape is mainly observed due to the moves of key players or brands, which include developments, product launches, joint ventures, mergers, and acquisitions that in turn change the view of the global face of the industry.

Market definition, market segmentation, key developments in the market, competitive analysis, and research methodology are the major topics in which this COVID-19 Saliva Screening Test Potential report is divided. This market report covers an array of factors that have an influence on the market and the keyword market industry, which includes industry insight and critical success factors (CSFs), market segmentation and value chain analysis, industry dynamics, drivers, restraints, key opportunities, technology and application outlook, country-level and regional analysis, competitive landscape, company market share analysis, and key company profiles. For sound decision-making and superior management of goods and services, these days businesses are adopting a market research report solution.

Gain clarity on industry shifts, growth areas, and forecasts in our COVID-19 Saliva Screening Test Potential Market report. Get your copy:
https://www.databridgemarketresearch.com/reports/global-covid-19-saliva-screening-test-potential-market

COVID-19 Saliva Screening Test Potential Market Review

Segments

- By Test Type
- Molecular Tests
- Antigen Tests
- Antibody Tests
- By End User
- Hospitals
- Diagnostic Laboratories
- Home Care Settings
- Others

Saliva testing for COVID-19 has emerged as a convenient and non-invasive method for screening individuals. The global market for COVID-19 saliva screening tests is expected to witness significant growth due to the ease of sample collection, reduced discomfort for patients, and potential for mass testing. The market can be segmented based on test type, including molecular tests, antigen tests, and antibody tests. Molecular tests are currently the most widely used for detecting the genetic material of the virus in saliva samples. Antigen tests are also gaining popularity for quick and cost-effective screening. Antibody tests help in identifying past infections and immune response. In terms of end users, the market caters to hospitals, diagnostic laboratories, home care settings, and others, providing flexibility in testing locations and accessibility.

Market Players

- Quest Diagnostics
- Roche Diagnostics
- Siemens Healthineers
- Abbott Laboratories
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Quidel Corporation
- PerkinElmer
- Hologic, Inc.
- Becton, Dickinson and Company

Several key players are actively contributing to the global COVID-19 saliva screening test market. Quest Diagnostics, Roche Diagnostics, and Siemens Healthineers are among the leading companies investing in developing and commercializing saliva-based testing solutions. Abbott Laboratories and Bio-Rad Laboratories are also prominent players with a focus on offering accurate and reliable testing platforms. Thermo Fisher Scientific and Quidel Corporation have introduced innovative technologies to enhance testing efficiency. PerkinElmer, Hologic, Inc., and Becton, Dickinson and Company are actively engaged in expanding their product portfolios to meet the growing demand for saliva screening tests. These market players are leveraging their research capabilities and distribution networks to meet the evolving needs of healthcare systems worldwide.

The global market for COVID-19 saliva screening tests has seen a surge in demand and innovation in response to the ongoing pandemic. Advancements in testing technology and the convenience of saliva-based tests have made them a preferred choice for individuals and healthcare providers alike. One key trend shaping the market is the development of rapid and accurate tests that can deliver results quickly, allowing for timely identification and containment of the virus. Market players are investing heavily in research and development to enhance the sensitivity and specificity of saliva tests, ensuring reliable results for screening and diagnostic purposes.

Furthermore, the market for COVID-19 saliva screening tests is witnessing collaborations and partnerships between key industry players and healthcare organizations to expand testing capabilities and reach a wider population. These strategic alliances aim to strengthen distribution networks, improve testing infrastructure, and enhance the availability of testing kits in various healthcare settings. Such partnerships also facilitate the sharing of knowledge and expertise, leading to the development of more effective testing solutions and protocols.

Moreover, the adoption of saliva testing for COVID-19 is not limited to traditional healthcare facilities but has also gained traction in non-clinical settings such as schools, workplaces, and community centers. The ease of sample collection and reduced need for trained healthcare professionals make saliva tests a practical and cost-effective option for mass screening and surveillance programs. This expansion of testing beyond hospitals and diagnostic laboratories underscores the growing importance of decentralized testing approaches in managing public health crises like the COVID-19 pandemic.

Additionally, regulatory bodies and government agencies play a crucial role in shaping the market landscape for COVID-19 saliva screening tests. Stringent regulations and guidelines regarding test validation, performance, and reporting standards are essential for ensuring the accuracy and reliability of test results. Market players must adhere to these regulatory requirements to gain approval for their testing products and maintain consumer trust in the effectiveness of saliva-based testing methods.

In conclusion, the global market for COVID-19 saliva screening tests is dynamic and evolving, driven by technological advancements, strategic partnerships, expanding testing locations, and regulatory oversight. The market is poised for continued growth as the demand for reliable and accessible testing solutions remains high. Market players need to focus on innovation, quality assurance, and collaboration to meet the evolving needs of healthcare systems and contribute to the global efforts in controlling the spread of COVID-19 through effective screening and testing strategies.The global market for COVID-19 saliva screening tests is experiencing a paradigm shift with the adoption of saliva-based testing methods. This shift is driven by the convenience, non-invasive nature, and potential for mass testing offered by saliva tests. Market players are focusing on developing innovative testing solutions to cater to the increasing demand for accurate and efficient COVID-19 screening. The market segmentation based on test types such as molecular tests, antigen tests, and antibody tests provides a diversified range of options for healthcare providers and individuals. Molecular tests are currently dominating the market for detecting the genetic material of the virus, while antigen tests offer quick and cost-effective screening solutions. Antibody tests play a crucial role in identifying past infections and immune responses, contributing to a comprehensive approach to COVID-19 screening.

Key industry players such as Quest Diagnostics, Roche Diagnostics, Siemens Healthineers, and Abbott Laboratories are at the forefront of driving advancements in saliva screening tests. These companies are investing in research and development to enhance the sensitivity and specificity of tests, ensuring accurate results for screening and diagnostic purposes. Collaborations and partnerships between market players and healthcare organizations are further expanding testing capabilities and reaching a wider population. These strategic alliances aim to strengthen distribution networks, improve testing infrastructure, and enhance the availability of testing kits across various healthcare settings.

Regulatory bodies and government agencies are playing a pivotal role in shaping the market landscape for COVID-19 saliva screening tests by setting stringent regulations and guidelines for test validation, performance, and reporting standards. Compliance with these regulations is crucial for gaining approval for testing products and maintaining consumer trust in the efficacy of saliva-based testing methods. The market's evolution towards decentralized testing approaches in non-clinical settings like schools, workplaces, and community centers underscores the importance of accessibility and affordability in scaling up COVID-19 screening efforts.

As the demand for reliable and accessible COVID-19 testing solutions continues to rise, market players must prioritize innovation, quality assurance, and collaboration to meet the evolving needs of healthcare systems. The market's trajectory is poised for sustained growth as technological advancements, strategic partnerships, and regulatory oversight shape the future of COVID-19 saliva screening tests. By staying abreast of market trends and investing in research and development, market players can contribute significantly to global efforts in controlling the spread of the virus through effective screening and testing strategies.

Uncover the company’s portion of market ownership
https://www.databridgemarketresearch.com/reports/global-covid-19-saliva-screening-test-potential-market/companies

Structured Market Research Questions for COVID-19 Saliva Screening Test Potential Market

• What is the present size of the global COVID-19 Saliva Screening Test Potential industry?


• What annual growth rate is projected for the COVID-19 Saliva Screening Test Potential sector?


• What are the main segment divisions in the COVID-19 Saliva Screening Test Potential Market report?


• Who are the established players in the global COVID-19 Saliva Screening Test Potential Market?


• What geographic areas are explored in the COVID-19 Saliva Screening Test Potential Market report?


• Who are the leading manufacturers and service providers for COVID-19 Saliva Screening Test Potential Market?